Skip to main content
SpringerLink
Log in

Irrational use of proton pump inhibitors in general practise

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

Proton pump inhibitors (PPI) are widely used among general practitioners (GP) and hospital doctors alike as a first-line agent for the management of various approved conditions. However, PPIs do have an established side-effect profile that can be over looked when prescribing these agents outside of their Food Drug Administration (FDA) indications.

Aims

The aim of this audit is to establish that PPIs are often prescribed without any clear documented indication as to why, particularly in the elderly population, despite multiple previous studies conducted which showed an over-use of these medicines.

Methods

We conducted a retrospective observational study of the patients admitted to an acute hospital in Ireland in February 2018. A cohort of patient charts were pulled from medical records and reviewed. Medical notes, GP letters, discharge summaries and prescriptions were reviewed in order to establish the primary indication for PPI prescription.

Results

One hundred seventy-four (n = 174) inpatient records were randomly assessed during the audit. Of these patients, 85 of them were taking PPIs regularly. 54.7% (n = 46) were prescribed a PPI without any documented indication. 46.4% (n = 39) of these patients were > 75 years of age. 54.7% (n = 46) of patients were prescribed esomeprazole. The commonest indication for prescribing PPIs was to reduce the risk of gastric ulceration associated with NSAID use, which was 68.4% (n = 26) of those who were prescribed a PPI in accordance with guidelines.

Conclusion

Irrational prescribing of PPIs continues both in hospital and in general practise. It is imperative that the side-effects of these medicines are weighed against the benefit and cost effectiveness, especially in the elderly population where polypharmacy remains a substantial concern.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sachs G, Shin JM, Howden CW (2006) Review article: The clinical pharmacology of proton pump inhibitors. Alimentary Pharmacol Ther 23:2–8. https://doi.org/10.1111/j.1365-2036.2006.02943

    Article  CAS  Google Scholar 

  2. Dean, Laura (2010). Comparing proton pump inhibitors. PubMed Health. Retrieved 16 July 2016

  3. Rossi S, editor. Australian medicines handbook 2006. Adelaide: Australian Medicines Handbook; 2006. ISBN 0-9757919-2-34

  4. Muhammad Haroon, Faiza Yasin, Syed K M Gardezi, Fahd Adeeb, and Frank Walker. Inappropriate use of proton pump inhibitors among medical inpatients: a questionnaire-based observational study. JRSM Short Rep 2013 Aug; 4(8)

  5. Chia CTW, Lim WP, Vu CKF (2014) Inappropriate use of proton pump inhibitors in a local setting. Singap Med J 55(7):363–366

    Article  Google Scholar 

  6. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA (2010) Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 170:772–778

    Article  PubMed  Google Scholar 

  7. Howell MD, Novack V, Grgurich P et al (2010) Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 170:784–790

    Article  PubMed  Google Scholar 

  8. Benjamin Lazarus, MBBS, Yuan Chen, MS, Francis P. Wilson, MD, MS,3 Yingying Sang, MS,1 Alex R. Chang, MD, MS,4 Josef Coresh, MD, PhD,1,5 and Morgan E. Grams, MD, PhD1,5 Proton pump inhibitor use and risk of chronic kidney disease, JAMA Intern Med 2016 Feb 1; 176(2): 238–246

  9. Corleto VD, Festa S, Di Giulio E, Annibale B (2014) Proton pump inhibitor therapy and potential long-term harm. Curr Opin Endocrinol Diabetes Obes 21(1):3–8. https://doi.org/10.1097/MED.0000000000000031

  10. B MG, Bennett K, Tilson L, Barry M (2005) Cost effective prescribing of proton pump inhibitors (PPI's) in the GMS Scheme. Ir Med J 98(3):78–80

    Google Scholar 

  11. The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial. Moayyedi P, Armstrong D, Hunt RH, Lei Y, Bukoski M, White RJ Am J Gastroenterol. 2010 Nov; 105(11):2341–6

  12. Bhatnagar P, Wickramasinghe K, Wilkins E, et al, Trends in the epidemiology of cardiovascular disease in the UK heart published online first: 22 August 2016. doi: 10.1136/heartjnl-2016-309573

  13. El-Serag HB, Sweet S, Winchester CC, Dent J (2014) Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 63(6):871–880

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. General Internal Medicine, Our Lady’s Hospital, Moathill, Navan, County Meath, Ireland

    Osama Ali, Mary Okon & Sheevam Maunick

  2. Medical Basic Specialist Training Programme, Our Lady’s Hospital, Moathill, Navan, County Meath, Ireland

    Robyn Poole & Emma Troy

  3. Royal College of Physicians of Ireland, Kildare Street, Dublin, Ireland

    Robyn Poole & Emma Troy

Authors
  1. Osama Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robyn Poole
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mary Okon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sheevam Maunick
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Emma Troy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Osama Ali.

Ethics declarations

Ethical approval was sought and granted by the institutional ethics committee at Our Lady’s Hospital, Navan.

Conflict of interest

The authors declare that they have no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, O., Poole, R., Okon, M. et al. Irrational use of proton pump inhibitors in general practise. Ir J Med Sci 188, 541–544 (2019). https://doi.org/10.1007/s11845-018-1891-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-018-1891-1

Keywords

Search

Navigation